A cross-sectional comparative analysis of quality of life and cost-effectiveness for retrospective dialysis and kidney transplant patients

Abstract

Dialysis, including hemodialysis (HD) and peritoneal dialysis, is initiated when kidney function deteriorates to a glomerular filtration rate below the normal range. In addition, dialysis manages renal failure through diffusion and ultrafiltration but does not completely replace kidney function. Conversely, kidney transplantation involves replacing a diseased kidney with a healthy donor kidney, offering restored kidney function and improved quality of life (QoL). Herein, this review compares the QoL and cost-effectiveness of dialysis versus kidney transplantation for patients with end-stage renal disease (ESRD). Transplant recipients generally report better physical and mental well-being, higher independence, and greater overall life satisfaction compared to dialysis patients. Economically, kidney transplantation, despite its high initial costs, proves more cost-effective in the long run due to reduced ongoing healthcare expenses. Dialysis, particularly in-center HD, incurs higher long-term costs. The findings advocate prioritizing kidney transplantation for eligible ESRD patients while also emphasizing the need for improved support for dialysis patients.

Keywords

Quality of life / Cost-effectiveness / Kidney transplant / Dialysis / End-stage renal disease

Funding

None.

Conflict of interest

The authors declare no conflicts of interest.

References

[1] Cohen A., Ioannidis K., Ehrlich A., Regenbaum S., Cohen M., Ayyash M., et al. (2021). Mechanism and reversal of drug-induced nephrotoxicity on a chip. Journal of Translational Medicine, 13:eabd6299. https://doi.org/10.1126/scitranslmed.abd6299

[2] Abdi F., Alinia C., Taghizadeh Afshari A., & Yusefzadeh H. (2022). Cost-benefit analysis of kidney transplant in patients with chronic kidney disease: A case study in Iran. Cost Effectiveness and Resource Allocation, 20:37. https://doi.org/10.1186/s12962-022-00372-1

[3] Abramyan S., & Hanlon M. (2024). Kidney transplantation. In: StatPearls. TreasureIsland, FL: StatPearls Publishing.

[4] Alonso J., Ferrer M., & Gandek B. (2004). Health-related quality of life measurement in clinical practice: A critical review of patient-reported outcome measures. Value in Health, 7(1):17-28. https://doi.org/10.1023/B:QURE.0000015298.09085.b0

[5] Alscher D.M. (2005). Principles of peritoneal dialysis. EDTNA‐ERCA Journal, 31(3):124-129. https://doi.org/10.1111/j.1755-6686.2005.tb00410.x

[6] Amerling R., Glezerman I., Savmnsky E., Dubrow A., & Ronco C. (2003). Continuous flow peritoneal dialysis: Current perspectives. Contributions to Nephrology, 140:294-304. https://doi.org/10.1159/000071402

[7] Au E., Wong G., & Chapman J.R. (2018). Cancer in kidney transplant recipients. Nature Reviews Nephrology, 14(8):508-520. https://doi.org/10.1038/s41581-018-0022-6

[8] Dasdelen S., & Grebe S. Infections after renal transplantation. LaboratoriumsMedizin, 41(S1):20170094. https://doi.org/10.1515/labmed-2017-0094

[9] Ferhatoğlu M.F., Kartal A., Kıvılcım T., Filiz A.İ., Kebudi A., & Gürkan A. (2019). Retrospective analysis of the first 100 kidney transplants at the Istanbul Okan University, Health Application and Research Center. Medical Bulletin of Sisli Etfal Hospital, 53(3):221-227. https://doi.org/10.14744/SEMB.2019.54533

[10] Gabolde M., Hervé C., & Moulin A.M. (2001). Evaluation, selection, and follow-up of live kidney donors: A review of current practice in French renal transplant centres. Nephrology Dialysis Transplantation, 16(10):2048-2052. https://doi.org/10.1093/ndt/16.10.2048

[11] Gordon E.J., & Sehgal A.R. (2000). Patient-nephrologist discussion about kidney transplantation as a treatment option. American Journal of Kidney Diseases, 36(1):140-149. https://doi.org/10.1053/rr.2000.5268

[12] Hays R.D., & McClellan W.M. (2018). Economic considerations in the management of chronic kidney disease. American Journal of Kidney Diseases, 71(5):737-745.

[13] Iqbal M.M., Rahman N., Alam M., Nath P.K., Waheed S., Islam K., et al. (2020). Quality of life is improved in renal transplant recipients versus that shown in patients with chronic kidney disease with or without dialysis. Experimental and Clinical Transplantation: Official Journal of the Middle East Society for Organ Transplantation, 18(Suppl 1):64-67. https://doi.org/10.6002/ect.TOND-TDTD2019.P11

[14] Kaufman D., Roberts W.C., & Roan C.L. (2019). The future of telemedicine in measuring patient quality of life: Opportunities and challenges. Telemedicine and e-Health, 25(10):898-905. https://doi.org/10.1258/135763307783064340

[15] Kiberd B.A., Keown P. (2014). Cost-effectiveness of kidney transplantation versus dialysis: A review of the literature. American Journal of Kidney Diseases, 64(4):513-523.

[16] Kumar S., & Sharma A. (2020). Equity in kidney transplantation: Current challenges and future directions. Transplantation Proceedings, 52(5):1437-1442.

[17] Liyanage T., Toyama T., Hockham C., Ninomiya T., Perkovic V., Woodward M., et al. (2022). Prevalence of chronic kidney disease in Asia: A systematic review and analysis. BMJ Global Health, 7(1):e007525. https://doi.org/10.1136/bmjgh-2021-007525

[18] Maglakelidze N., Pantsulaia T., Tchokhonelidze I., Managadze L., & Chkhotua A. (2011). Assessment of health-related quality of life in renal transplant recipients and dialysis patients. Transplantation Proceedings, 43(1):376-379. https://doi.org/10.1016/j.transproceed.2010.12.015

[19] Marroquin C.E. (2019). Patient selection for kidney transplant. Surgical Clinics, 99(1):1-35. https://doi.org/10.1016/j.suc.2018.09.002

[20] Mehrotra R., Devuyst O., Davies S.J., & Johnson D.W. (2016). The current state of peritoneal dialysis. Journal of the American Society of Nephrology, 27(11):3238-3252. https://doi.org/10.1681/ASN.2016010112

[21] Mihalopoulos M., Yaghoubian A., Razdan S., Khusid J.A., Mehrazin R., Badani K.K., et al. (2022). Understanding the link between kidney stones and cancers of the upper urinary tract and bladder. American Journal of Clinical and Experimental Urology, 10(5):277-298.

[22] Miller R.R., & McLachlan C. (2016). The role of quality of life and cost-effectiveness analyses in healthcare decision-making for kidney failure treatment. Health Policy, 120(2):163-172.

[23] Murdeshwar H.N., & Anjum F. (2020). Hemodialysis. In: StatPearls. TreasureIsland, FL: StatPearls Publishing.

[24] Olsson R., & Helgesson J. (2019). Economic evaluation of kidney transplantation: A systematic review. Journal of Health Economics, 65:123-135. https://doi.org/10.1097/TP.0000000000000079

[25] Parker T.S., & Molzahn A.E. (2017). Comparing quality of life in dialysis and kidney transplant patients: A systematic review and meta-analysis. Journal of Nephrology, 30(6):715-726.

[26] Raimann J.G., & Kuhlmann M.K. (2016). Cost-effectiveness of renal replacement therapies: A review. Nephrology Dialysis Transplantation, 31(10):1611-1622. https://doi.org/10.1093/ndt/gfq780

[27] Rosselli D., Rueda J.D., & Diaz C.E. (2015). Cost-effectiveness of kidney transplantation compared with chronic dialysis in end-stage renal disease. Saudi Journal of Kidney Diseases and Transplantation, 26(4):733-738. https://doi.org/10.4103/1319-2442.160175

[28] Santosh R., Mohammed Y.N., Rahaman Z., & Khurana S. (2024). The role of telemedicine in enhancing chronic kidney disease (CKD) management and dialysis care. Cureus, 16(3):e55816. https://doi.org/10.7759/cureus.55816

[29] Sarhan A.L., Jarareh R.H., & Shraim M. (2021). Quality of life for kidney transplant recipients and hemodialysis patients in Palestine: A cross-sectional study. BMC Nephrology, 22:210. https://doi.org/10.1186/s12882-021-02412-z

[30] Shtepa O., Kuryata O., & Halushchak O. (2022). Impact of the duration of program hemodialysis and heart failure on the pattern of lipid profile in patients with end-stage chronic kidney disease. Atherosclerosis Journal, 355:203C. https://doi.org/10.3390/healthcare5030052

[31] Stachowska-Pietka J., Waniewski J., & Lindholm B. (2015). Peritoneal dialysis:Principles and peritoneal physiology. In: Oxford Textbook of Clinical Nephrology. United Kingdom: Oxford University Press, p. 2260-2273.

[32] Swan M. (2012). The quantified self: Fundamental disruption in big data science and biological discovery. Big Data, 1(2):85-99. https://doi.org/10.1089/big.2012.0002

[33] Tepel M., Alkaff F.F., Kremer D., Bakker S.J., Thaunat O., Nagarajah S., et al. (2022a). Pretransplant endotrophin predicts delayed graft function after kidney transplantation. Scientific reports, 12(1):4079. https://doi.org/10.1038/s41598-022-07645-y

[34] Tepel M., Nagarajah S., Saleh Q., Thaunat O., Bakker S.J., van den Born J., et al. (2022b). Pretransplant characteristics of kidney transplant recipients that predict posttransplant outcome. Frontiers in Immunology, 13:945288. https://doi.org/10.3389/fimmu.2022.945288

[35] Tonelli M, Wiebe N, Knoll G, Bello A, Browne S, Jadhav D, et al. Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes. Am J Transplant 2011;11:2093-109. https://doi.org/10.1111/j.1600-6143.2011.03686.x

[36] Van Mil D., Pouwels X.G., Heerspink H.J., & Gansevoort R.T. (2024). Cost-effectiveness of screening for chronic kidney disease: Existing evidence and knowledge gaps. Clinical Kidney Journal, 17(1):sfad254. https://doi.org/10.1093/ckj/sfad254

[37] Wang J.H., Skeans M.A., & Israni A.K. (2016). Current status of kidney transplant outcomes: Dying to survive. Advances in Chronic Kidney Disease, 23(5):281-286. https://doi.org/10.1053/j.ackd.2016.07.001

[38] Ye H., Ding H., Gan W., Wen P., Zhou Y., Cao H., et al. (2020). Hemodialysis. In: Chronic Kidney Disease:Diagnosis and Treatment. Germany: Springer, p. 209-231. https://doi.org/10.52403/ijhsr.20230227